|
|
hair cycle
|
GO:0042633 |
28 |
0.781
|
|
|
|
golgi to plasma membrane cftr protein transport
|
GO:0043000 |
1 |
0.705
|
Human |
|
|
intermediate filament based process
|
GO:0045103 |
17 |
0.672
|
Human |
|
|
keratinization
|
GO:0031424 |
2 |
0.475
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
2 |
0.367
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.362
|
Human |
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
17 |
0.337
|
Human |
|
|
skin development
|
GO:0043588 |
76 |
0.292
|
Human |
|
|
keratinocyte differentiation
|
GO:0030216 |
36 |
0.275
|
Human |
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.274
|
Human |
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.271
|
Human |
|
|
epidermis morphogenesis
|
GO:0048730 |
3 |
0.258
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.233
|
Human |
|
|
intermediate filament organization
|
GO:0045109 |
10 |
0.233
|
Human |
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.211
|
Human |
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.211
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.186
|
Human |
|
|
response to lipid
|
GO:0033993 |
206 |
0.181
|
Human |
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.181
|
Human |
|
|
actin filament based process
|
GO:0030029 |
224 |
0.179
|
Human |
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.174
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.173
|
Human |
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.169
|
Human |
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.166
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.164
|
|
|
|
epidermis development
|
GO:0008544 |
59 |
0.163
|
Human |
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.155
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.148
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.142
|
Human |
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.142
|
Human |
|
|
membrane organization
|
GO:0061024 |
292 |
0.142
|
Human |
|
|
cell development
|
GO:0048468 |
328 |
0.123
|
Human |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.121
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.119
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.119
|
Human |
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
207 |
0.114
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.109
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.108
|
Human |
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.105
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.105
|
Human |
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.103
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.103
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.103
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.099
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.098
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.096
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.094
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.094
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.091
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.090
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.090
|
Human |
|
|
molting cycle
|
GO:0042303 |
28 |
0.090
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.088
|
Human |
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.088
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.087
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.084
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.083
|
Human |
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.083
|
Human |
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.082
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.080
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.080
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.079
|
Human |
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.077
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.075
|
Human |
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.073
|
Human |
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.073
|
Human |
|
|
defense response
|
GO:0006952 |
315 |
0.071
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.070
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.069
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.068
|
Human |
|
|
metal ion transport
|
GO:0030001 |
272 |
0.067
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.067
|
Human |
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.067
|
Human |
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.065
|
|
|
|
golgi vesicle transport
|
GO:0048193 |
80 |
0.065
|
Human |
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.064
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.061
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.061
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.060
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.060
|
Human |
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.060
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.060
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.060
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.058
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.058
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.057
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.056
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.056
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.055
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.055
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.055
|
|
|
|
system process
|
GO:0003008 |
349 |
0.053
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.053
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.052
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.052
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
93 |
0.052
|
Human |
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.052
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.051
|
Human |
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.051
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.050
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.050
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.050
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.050
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.049
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
117 |
0.049
|
|
|
|
keratinocyte activation
|
GO:0032980 |
1 |
0.049
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.048
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.047
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.047
|
Human |
|
|
muscle structure development
|
GO:0061061 |
98 |
0.047
|
Human |
|
|
post golgi vesicle mediated transport
|
GO:0006892 |
36 |
0.047
|
Human |
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.046
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.046
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.046
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.046
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.046
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
43 |
0.045
|
Human |
|
|
cell adhesion
|
GO:0007155 |
325 |
0.045
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.045
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.044
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.044
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
47 |
0.044
|
|
|
|
adenylate cyclase inhibiting serotonin receptor signaling pathway
|
GO:0007198 |
2 |
0.043
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.043
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
152 |
0.043
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.043
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.042
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.042
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
87 |
0.042
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.042
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.041
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.041
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.041
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.041
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.040
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.040
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
78 |
0.039
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.039
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.039
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.039
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.039
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.038
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.038
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.038
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.038
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.038
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.037
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.037
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.037
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.037
|
|
|
|
muscle contraction
|
GO:0006936 |
73 |
0.037
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.036
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.036
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
73 |
0.036
|
Human |
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
43 |
0.036
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
89 |
0.036
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.036
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.036
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.036
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.035
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.035
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.035
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.035
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.035
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.034
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.034
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.034
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.034
|
Human |
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.034
|
|
|
|
sarcomere organization
|
GO:0045214 |
8 |
0.033
|
Human |
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.033
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.033
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.033
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.033
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.033
|
|
|
|
intermediate filament bundle assembly
|
GO:0045110 |
5 |
0.033
|
Human |
|
|
negative regulation of insulin secretion involved in cellular response to glucose stimulus
|
GO:0061179 |
1 |
0.033
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.033
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.032
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.032
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.032
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
67 |
0.032
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.032
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.032
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
73 |
0.032
|
|
|
|
activation of mapk activity by adrenergic receptor signaling pathway
|
GO:0071883 |
3 |
0.032
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.031
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.031
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.031
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.031
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.031
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.031
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.031
|
|
|
|
camp metabolic process
|
GO:0046058 |
61 |
0.031
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.031
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.030
|
|
|
|
specification of organ identity
|
GO:0010092 |
3 |
0.030
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.030
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.030
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.030
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.030
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.030
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.030
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.030
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.030
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.030
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.030
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.030
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
68 |
0.029
|
Human |
|
|
response to wounding
|
GO:0009611 |
168 |
0.029
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.029
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.029
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.029
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.029
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
82 |
0.029
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.029
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.028
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.028
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.028
|
|
|
|
humoral immune response
|
GO:0006959 |
49 |
0.028
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.028
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.028
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.028
|
|
|
|
muscle cell development
|
GO:0055001 |
29 |
0.028
|
Human |
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.027
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.027
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.027
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
22 |
0.027
|
|
|
|
adenylate cyclase inhibiting adrenergic receptor signaling pathway
|
GO:0071881 |
1 |
0.027
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.027
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.027
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.027
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.027
|
|
|
|
epidermal growth factor activated receptor transactivation by g protein coupled receptor signaling pathway
|
GO:0035625 |
4 |
0.027
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.027
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.027
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.027
|
|
|
|
positive regulation of phosphatidylinositol biosynthetic process
|
GO:0010513 |
3 |
0.027
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.027
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
24 |
0.027
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.026
|
|
|
|
memory
|
GO:0007613 |
3 |
0.026
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.026
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.026
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.026
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
43 |
0.026
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.026
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.026
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.025
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
17 |
0.025
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.025
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.025
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
17 |
0.025
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.025
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.025
|
|
|
|
camp mediated signaling
|
GO:0019933 |
23 |
0.025
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.025
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.025
|
Human |
|
|
maintenance of location
|
GO:0051235 |
112 |
0.025
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.025
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
19 |
0.025
|
|
|
|
phospholipase c activating adrenergic receptor signaling pathway
|
GO:0071882 |
1 |
0.024
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.024
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.024
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.024
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.024
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.024
|
|
|
|
sensory perception of pain
|
GO:0019233 |
4 |
0.024
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.024
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
4 |
0.024
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.024
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.024
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.024
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.024
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.024
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.024
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.024
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.024
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.024
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.023
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.023
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.023
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
50 |
0.023
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.023
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.023
|
|
|
|
tissue homeostasis
|
GO:0001894 |
63 |
0.023
|
|
|
|
cellular potassium ion transport
|
GO:0071804 |
60 |
0.023
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
60 |
0.023
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.023
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.023
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.023
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
52 |
0.023
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.022
|
|
|
|
phospholipase c activating g protein coupled receptor signaling pathway
|
GO:0007200 |
15 |
0.022
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.022
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.022
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.022
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
82 |
0.022
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.022
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.022
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.022
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.022
|
|
|
|
activation of protein kinase activity
|
GO:0032147 |
90 |
0.022
|
|
|
|
amide transport
|
GO:0042886 |
76 |
0.022
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.022
|
|
|
|
aging
|
GO:0007568 |
66 |
0.022
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.022
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.021
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.021
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
85 |
0.021
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.021
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.021
|
|
|
|
steroid metabolic process
|
GO:0008202 |
94 |
0.021
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.021
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.021
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.021
|
Human |
|
|
desensitization of g protein coupled receptor protein signaling pathway by arrestin
|
GO:0002032 |
2 |
0.021
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.021
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.021
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.021
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.021
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.021
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.021
|
|
|
|
golgi to plasma membrane protein transport
|
GO:0043001 |
19 |
0.021
|
Human |
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.021
|
|
|
|
growth
|
GO:0040007 |
202 |
0.021
|
|
|
|
striated muscle cell development
|
GO:0055002 |
27 |
0.020
|
Human |
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.020
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
59 |
0.020
|
Human |
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.020
|
|
|
|
negative regulation of catabolic process
|
GO:0009895 |
104 |
0.020
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
108 |
0.020
|
|
|
|
anion transport
|
GO:0006820 |
161 |
0.020
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.020
|
Human |
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.020
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.020
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.020
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.020
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.020
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.020
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.020
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.020
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.020
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.020
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.020
|
|
|
|
golgi to plasma membrane transport
|
GO:0006893 |
21 |
0.020
|
Human |
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.020
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.020
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.019
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.019
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.019
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.019
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.019
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.019
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.019
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
1 |
0.019
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.019
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.019
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
49 |
0.019
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.019
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.019
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.019
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.019
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.019
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
50 |
0.018
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.018
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.018
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.018
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.018
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
80 |
0.018
|
|
|
|
positive regulation of steroid hormone biosynthetic process
|
GO:0090031 |
2 |
0.018
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.018
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
3 |
0.018
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.018
|
|
|
|
protein secretion
|
GO:0009306 |
98 |
0.018
|
|
|
|
detection of chemical stimulus involved in sensory perception of smell
|
GO:0050911 |
2 |
0.018
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
58 |
0.018
|
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.018
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.018
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.018
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.018
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.018
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.018
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.018
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.017
|
|
|
|
regulation of behavior
|
GO:0050795 |
82 |
0.017
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.017
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
52 |
0.017
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.017
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
3 |
0.017
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.017
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.017
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.017
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.017
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.017
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.017
|
|
|
|
signal release
|
GO:0023061 |
70 |
0.017
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.017
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.017
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.017
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.017
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.017
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.017
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
82 |
0.017
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.017
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.017
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.017
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.017
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.017
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.017
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.017
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.017
|
|
|
|
viral life cycle
|
GO:0019058 |
132 |
0.017
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.017
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.017
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.016
|
|
|
|
serotonin receptor signaling pathway
|
GO:0007210 |
11 |
0.016
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.016
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.016
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.016
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.016
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
79 |
0.016
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.016
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.016
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.016
|
|
|
|
cyclic nucleotide mediated signaling
|
GO:0019935 |
26 |
0.016
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.016
|
|
|
|
response to fungus
|
GO:0009620 |
4 |
0.016
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.016
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
63 |
0.016
|
|
|
|
leukocyte migration
|
GO:0050900 |
107 |
0.016
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.016
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.016
|
|
|
|
regulation of g protein coupled receptor protein signaling pathway
|
GO:0008277 |
35 |
0.016
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.016
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.016
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.016
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.016
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.016
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.016
|
|
|
|
hormone transport
|
GO:0009914 |
68 |
0.016
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.016
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.016
|
|
|
|
lipid catabolic process
|
GO:0016042 |
84 |
0.016
|
|
|
|
negative regulation of wnt protein secretion
|
GO:0061358 |
1 |
0.016
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.015
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
75 |
0.015
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.015
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.015
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.015
|
|
|
|
regulation of cyclase activity
|
GO:0031279 |
19 |
0.015
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.015
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.015
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
38 |
0.015
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.015
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.015
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
74 |
0.015
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.015
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.015
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
61 |
0.015
|
|
|
|
receptor transactivation
|
GO:0035624 |
4 |
0.015
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.015
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.015
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
65 |
0.015
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
57 |
0.015
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.015
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
38 |
0.015
|
|
|
|
protein import into nucleus
|
GO:0006606 |
104 |
0.015
|
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.015
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.015
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.015
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.014
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.014
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.014
|
|
|
|
regulation of viral process
|
GO:0050792 |
103 |
0.014
|
|
|
|
adenylate cyclase inhibiting opioid receptor signaling pathway
|
GO:0031635 |
1 |
0.014
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.014
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.014
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.014
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.014
|
|
|
|
behavioral response to ethanol
|
GO:0048149 |
2 |
0.014
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.014
|
|
|
|
tachykinin receptor signaling pathway
|
GO:0007217 |
3 |
0.014
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.014
|
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
41 |
0.014
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
47 |
0.014
|
|
